KUZANI PHARMACEUTICALS
Kuzani is developing novel medicines that can be routinely prescribed to and used by children to treat the underlying basis of autism during their key developmental years.
KUZANI PHARMACEUTICALS
Status:
Active
Current Employees Featured
Founder
More informations about "Kuzani Pharmaceuticals"
Kuzani 2025 Company Profile: Valuation, Funding & Investors
Kuzani General Information Description. Developer of novel medicines designed to treat the underlying basis of autism during children's key developmental years. The company's platform …See details»
Suramin Update: The Race is On! - N of One
Feb 12, 2021 Unlike the thinly-funded PaxMedica, Kuzani is backed by the deep pocketed Morningside Group and has been working with Dr. Naviaux for …See details»
Kuzani Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Kuzani Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Kuzani …See details»
Brent Vaughan - CEO & Co-Founder - Stealth TechBio | LinkedIn
Kuzani Pharmaceuticals, Inc. Apr 2017 - Nov 2023 6 years 8 ... REF is a global organization that brings together business leaders in peer advisory groups to enhance their leadership skills and ...See details»
Vaughan – Biotech Summit
Brent Vaughan is the co-founder and currently serves as a board member at Kuzani Pharmaceuticals, a developer of novel medicines designed to treat the underlying basis of …See details»
Brent Vaughan - Kuzani Pharmaceuticals, Inc. | LinkedIn
· Experience: Kuzani Pharmaceuticals, Inc. · Education: UC Davis · Location: Portola Valley · 500+ connections on LinkedIn. View Brent Vaughan’s profile on LinkedIn, a professional community ...See details»
Neurology - Morningside
Kuzani Pharmaceuticals. A Drug Treatment for Autism. Based on the hypothesis of the cell danger response underlying the autistic brain, an approved drug which is a purinergic receptor …See details»
Chief Executive Officer at Cognito Therapeutics - The Org
Prior to this, they were a Board Member and the CEO & Founder of Kuzani Pharmaceuticals, Inc., where they worked on advancing a new medicine for the treatment of pediatric autism. In …See details»
Kuzani Pharmaceuticals-动脉网 - vbdata.cn
Kuzani Pharmaceuticals由Brent Vaughan创建，致力于开发可以在儿童关键发育时期常规使用的自闭症新型药物。 动脉网APP 扫码下载See details»
Kuzani Pharmaceuticals - Crunchbase
Kuzani Pharmaceuticals is a that develops novel medicines that can be routinely prescribed to and used by children. New. Resources. Advanced Search. Start Free Trial . ... Experience the new Crunchbase, powered by AI . Organization. …See details»
Suramin sodium - Kuzani Pharmaceuticals - AdisInsight
Suramin is being developed by Kuzani Pharmaceuticals for the treatment of autism spectrum disorder [Pervasive child development disorders in the development Suramin sodium - Kuzani …See details»
Kuzani Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
Organization. Kuzani Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 4. About. Kuzani …See details»
KUZANI GROUP - K2015369340 - South Africa - B2BHint
Oct 19, 2015 KUZANI GROUP South African company, Company number: K2015369340, Incorporation Date Oct 20, 2015;, Address: 24 PITZER ROAD, GLEN AUSTIN, MIDRAND, …See details»
Feasibility, Safety, and Efficacy of Gamma Sensory Stimulation as a ...
Megerian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kuzani Pharmaceuticals. Dr. Megerian has received research support from …See details»
Cognito’s non-invasive medical device demonstrates durable …
Apr 9, 2024 Vaughan has received personal compensation for serving as an employee of Kuzani Pharmaceuticals, Inc. Mr. Vaughan has received personal compensation for serving as an …See details»
Qubit Pharmaceuticals - Crunchbase
Organization. Qubit Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... GeneScience Pharmaceuticals, and Kuzani Pharmaceuticals …See details»
Brent Vaughan Email & Phone Number - RocketReach
Brent Vaughan brings experience from previous roles at Cognito Therapeutics, Inc., Kuzani Pharmaceuticals, Inc. and Morningside. Brent Vaughan holds a 1989 - 1991 Master of …See details»
TRS 1060 - World Health Organization (WHO)
5 days ago Access to Medicines and Health Products (MHP), Health Product Policy and Standards (HPS), Norms and Standards for Pharmaceuticals (NSP), Technical Standards and …See details»
Brent Vaughan - Crunchbase Person Profile
Brent Vaughan is the CEO & Founder at Kuzani Pharmaceuticals. ... Kuzani Pharmaceuticals CEO & Founder Apr 2017. Organization Name . Title At Company . Start Date . End Date . …See details»
Coherent Activity in EEG Response to Gamma Sensory ... - Neurology
May 3, 2022 Megerian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kuzani Pharmaceuticals. Dr. Megerian has received research …See details»